StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Raymond James Upgrades Quest Diagnostics (DGX) to Outperform
April 21, 2017 5:50 AM
Raymond James upgraded Quest Diagnostics (NYSE: DGX) from Market Perform to Outperform with a price target of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Upgrades
Next Articles
Quest Diagnostics (DGX) PT Raised to $115 at Canaccord Genuity Following Strong 1Q Report; 'Continues to Prove Skeptics Wrong... Q1 was a Blowout'
April 24, 2017 9:35 AM
Quest Diagnostics (DGX) PT Raised to $115 at UBS; 'Improved Growth Profile Continues to Build Confidence'
April 24, 2017 9:14 AM
Quest Diagnostics (DGX) PT Raised to $115 at Deutsche Bank
April 21, 2017 8:26 AM
